• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化 2022 年年鉴

Cystic fibrosis year in review 2022.

机构信息

Department of Pediatrics, Children's Hospital of New Orleans, New Orleans, Louisiana, USA.

Department of Pediatrics, Tulane University, New Orleans, Louisiana, USA.

出版信息

Pediatr Pulmonol. 2023 Nov;58(11):3013-3022. doi: 10.1002/ppul.26641. Epub 2023 Aug 18.

DOI:10.1002/ppul.26641
PMID:37594137
Abstract

Remarkable medical advancements have been made for people with cystic fibrosis (CF) in recent years, with an abundance of research continuing to be conducted worldwide. With concern for limitations in access to highly effective CFTR modulators, as well as the recent Coronavirus Disease-19 pandemic, there has been a consistent effort to understand and improve CF screening, disease burden, diagnosis, and management. Our aim in this review is to present articles from 2022 with an emphasis on clinically relevant studies. We hope this will serve as a broad overview of the research published in the past year.

摘要

近年来,囊性纤维化(CF)患者的医学进展令人瞩目,全球范围内仍有大量研究正在进行。由于担心 CFTR 调节剂的获得受限,以及最近的冠状病毒病-19 大流行,人们一直在努力理解和改善 CF 的筛查、疾病负担、诊断和管理。我们在这篇综述中的目的是介绍 2022 年的文章,重点是临床相关研究。我们希望这将作为过去一年发表的研究的广泛概述。

相似文献

1
Cystic fibrosis year in review 2022.囊性纤维化 2022 年年鉴
Pediatr Pulmonol. 2023 Nov;58(11):3013-3022. doi: 10.1002/ppul.26641. Epub 2023 Aug 18.
2
[Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].[中国专家共识声明:囊性纤维化的诊断与治疗(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):352-372. doi: 10.3760/cma.j.cn112147-20221214-00971.
3
Advanced Cystic Fibrosis Lung Disease and Lung Transplantation in the Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulators.囊性纤维化跨膜电导调节因子调节剂时代的晚期囊性纤维化肺病和肺移植
Semin Respir Crit Care Med. 2023 Apr;44(2):260-268. doi: 10.1055/s-0042-1758731. Epub 2023 Mar 9.
4
Cystic fibrosis year in review 2021.囊性纤维化 2021 年年鉴
Pediatr Pulmonol. 2022 Jul;57(7):1590-1599. doi: 10.1002/ppul.25948. Epub 2022 May 27.
5
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.囊性纤维化的增效剂(针对III类和IV类突变的特定疗法)。
Cochrane Database Syst Rev. 2019 Jan 7;1(1):CD009841. doi: 10.1002/14651858.CD009841.pub3.
6
Acute Recurrent and Chronic Pancreatitis as Initial Manifestations of Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator-Related Disorders.急性复发性和慢性胰腺炎作为囊性纤维化和囊性纤维化跨膜电导调节因子相关疾病的初始表现。
Pancreas. 2019 Aug;48(7):888-893. doi: 10.1097/MPA.0000000000001350.
7
Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Review for the Otolaryngologist.囊性纤维化跨膜电导调节剂调节剂治疗:耳鼻喉科医生的综述。
Am J Rhinol Allergy. 2020 Jul;34(4):573-580. doi: 10.1177/1945892420912368. Epub 2020 Mar 13.
8
Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders.临床中的基因诊断:从囊性纤维化到CFTR相关疾病
Arch Pediatr. 2020 Feb;27 Suppl 1:eS25-eS29. doi: 10.1016/S0929-693X(20)30047-6.
9
Advances in the diagnosis and treatment of cystic fibrosis.囊性纤维化的诊断与治疗进展
Adv Pediatr. 2014 Aug;61(1):225-43. doi: 10.1016/j.yapd.2014.03.002. Epub 2014 May 3.
10
Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis.针对遗传缺陷:囊性纤维化跨膜电导调节剂调节剂在囊性纤维化中的作用。
Eur Respir Rev. 2013 Mar 1;22(127):58-65. doi: 10.1183/09059180.00008412.

引用本文的文献

1
Connexin 30 (GJB6) deletion as a cause of a false positive sweat test result.连接蛋白30(GJB6)缺失导致汗液试验结果假阳性。
Eur J Pediatr. 2025 Jun 12;184(7):416. doi: 10.1007/s00431-025-06220-7.
2
Fatty acid abnormalities in cystic fibrosis-the missing link for a cure?囊性纤维化中的脂肪酸异常——治愈的关键环节缺失?
iScience. 2024 Oct 11;27(11):111153. doi: 10.1016/j.isci.2024.111153. eCollection 2024 Nov 15.
3
Vancomycin in Pediatric Patients with Cystic Fibrosis: Dose Optimization Using Population Pharmacokinetic Approach.万古霉素在囊性纤维化儿科患者中的应用:基于群体药代动力学方法的剂量优化。
Eur J Drug Metab Pharmacokinet. 2024 Nov;49(6):677-687. doi: 10.1007/s13318-024-00913-4. Epub 2024 Sep 16.
4
Challenges of Preimplantation Genetic Counselling in the Context of Cystic Fibrosis and Other CFTR-Related Disorders: A Monocentric Experience in a Cohort of 92 Couples.囊胞性纤维症与其他 CFTR 相关疾病的胚胎植入前基因遗传咨询之挑战:92 对夫妻之单中心经验。
Genes (Basel). 2024 Jul 18;15(7):937. doi: 10.3390/genes15070937.